Pfiz­er says peni­cillin in­jec­tion may soon be in short sup­ply

Pfiz­er has no­ti­fied the FDA that there may be an im­pend­ing short­age of peni­cillin, cit­ing an in­crease in syphilis in­fec­tions and oth­er short­ages.

In a let­ter post­ed to the FDA’s web­site and dat­ed Mon­day, the phar­ma said there is “lim­it­ed sup­ply” and an “im­pend­ing stock out sit­u­a­tion” for pre­filled Bi­cillin L-A and Bi­cillin C-R sy­ringes, which are al­so used to treat pneu­mo­nia, strep throat and oth­er bac­te­r­i­al in­fec­tions. To al­le­vi­ate the pos­si­ble short­age, Pfiz­er said it’s pri­or­i­tiz­ing the pro­duc­tion of Bi­cillin L-A pre­filled sy­ringes, ac­cord­ing to a Pfiz­er spokesper­son.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER